No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors

Objectives: Data from a vaccine trial and from post-vaccine surveillance in the United Kingdom have suggested that the bivalent HPV-16/18 vaccine offers cross-protection against HPV-6/11 and protection against anogenital warts (AGW). We studied the effect of the bivalent vaccine on genital HPV-6/11 positivity and AGW in the Netherlands. Methods: We included all vaccine-eligible women from the PASSYON study, a biennial cross-sectional study among 16- to 24-year-old sexually transmitted infection (STI) clinic attendants. Vaginal self-swabs were analyzed for type specific HPV and AGW were diagnos... Mehr ...

Volltext
Verfasser: Woestenberg, Petra J.
King, Audrey J.
van der Sande, Marianne A. B.
Donken, Robine
Leussink, Suzan
van der Klis, Fiona R. M.
Hoebe, Christian J. P. A.
Bogaards, Johannes A.
van Benthem, Birgit H. B.
Dokumenttyp: Artikel
Erscheinungsdatum: 2017
Reihe/Periodikum: Woestenberg , P J , King , A J , van der Sande , M A B , Donken , R , Leussink , S , van der Klis , F R M , Hoebe , C J P A , Bogaards , J A , van Benthem , B H B , Med Microbiological Labs & Public Hlth Serv 2017 , ' No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors ' , Journal of Infection , vol. 74 , no. 4 , pp. 393-400 . https://doi.org/10.1016/j.jinf.2017.01.007
Schlagwörter: Human papillomavirus 6 / Human papillomavirus 11 / Condylomata acuminata / Warts / Vaccination / Human papillomavirus vaccine / L1 type 16 / 18 / Prevention & control / RISK HPV TYPES / GENITAL WARTS / INTRAEPITHELIAL NEOPLASIA / AS04-ADJUVANTED VACCINE / ANOGENITAL WARTS / CERVICAL-CANCER / PAPILLOMAVIRUS / NETHERLANDS / EFFICACY / WOMEN
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27597201
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://cris.maastrichtuniversity.nl/en/publications/91ca7b22-e7b9-411d-85e7-ac4f21b28968